One in 10 people with atopic dermatitis, the most common type of eczema, have symptoms on their feet. These quick facts can help you manage it.

The efficacy of ruxolitinib cream in pediatric patients shows that nonsteroidal management of atopic dermatitis is feasible, ...

New data highlight efficacy, safety, and time off treatment with as-needed ruxolitinib cream in pediatric atopic dermatitis.

The U.S. Food and Drug Administration (FDA) has signed off on the first-ever cream specifically approved for treating chronic ...

JERSEY CITY, N.J., July 07, 2025--Organon's steroid-free VTAMA (tapinarof) cream 1%, granted strong recommendation in American Academy of Dermatology guidelines for atopic dermatitis.

The American Academy of Dermatology has updated its guidelines for treating and managing atopic dermatitis with topical and ...

While some topical herbal therapies may provide benefit for patients with AD, systemic herbal therapies do not provide significant benefit.

Discover a study highlighting how tapinarof cream 1% delivers rapid, clinically significant itch relief in children and adults with atopic dermatitis.

From polyaphron technology to fixed combinations, new formulations improve tolerability, adherence, and patient satisfaction.

The American Academy of Dermatology (AAD) provided evidence-based recommendation for the use of ZORYVE® (roflumilast) cream 0.15% in adults with mild to moderate atopic dermatitis (AD ...